Carr Patricia
SVP, Chief Accounting Officer
Carr Patricia has filed 5 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Mar 9, 2026.
On the most recent filing, Carr Patricia is listed as SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc. Inside the rolling window, Carr Patricia reported no open-market purchases and 5 open-market sales totaling $2.5M in JAZZ. The largest disclosed transaction in the window is a sale of 5,319 JAZZ shares on Nov 18, 2025, worth $968K.
Companies traded
Other insiders at JAZZ
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Carr Patricia made?
Carr Patricia has filed 5 SEC Form 4 filings (12 transaction rows) across 1 company since 2025.
Which companies does Carr Patricia trade?
Carr Patricia has filed SEC Form 4 disclosures for 1 company, including JAZZ.
When was Carr Patricia's most recent SEC Form 4 filing?
Carr Patricia's most recent SEC Form 4 filing on Tracefour is dated Mar 9, 2026.
What is Carr Patricia's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Carr Patricia is listed as SVP, Chief Accounting Officer.
What is Carr Patricia's total buy and sell value in the current window?
Inside the rolling retention window, Carr Patricia bought $0 and sold $2.5M based on SEC Form 4 filings.
What was Carr Patricia's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,319 JAZZ shares on 2025-11-18, worth $968K, per SEC Form 4 filings.